Skip to main content
. 2023 Jun 29;61:102077. doi: 10.1016/j.eclinm.2023.102077

Table 1.

Outcome definitions and study populations.

Disease area
Diabetes Cardiovascular disease Respiratory disease Mental health
Clinical monitoring
 Outcomes measured HbA1c, blood pressure Blood pressure COPD annual review,1 asthma annual review2 Blood pressure
 Study population People with Type 1 DM or Type 2 DM as coded on primary care record any time prior to study entry People with coronary heart disease, history of stroke or TIA as coded in primary care record any time prior to study entry 1 people aged >40 with a COPD code prior to study entry,2 people with an asthma code in primary care record in the 3 years prior to study entry People with schizophrenia, bipolar disorder and other psychoses as coded in primary care record any time prior to study entry
Hospital admissions
 Outcomes measured Admission with primary reason type 1 DM, type 2 DM or diabetic ketoacidosis Admission with primary reason MI, stroke, heart failure or VTE Admission with primary reason asthma exacerbation in those with asthma1 or COPD exacerbation in those with COPD2 Admission with primary reason depression or anxiety
 Study population People with type 1 DM or type 2 DM code in primary care record any time prior to study entry General adult population 1 age >40 with COPD code prior to study entry,2 asthma code in primary care record in the 3 years prior to study entry General adult population

HbA1c: Haemoglobin A1c, COPD: chronic obstructive pulmonary disease, DM: diabetes mellitus, TIA: transient ischaemic attack, MI: myocardial infarction, VTE: venous thromboembolism.